MRNS - Marinus Pharmaceuticals, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue---
Cost of Revenue---
Gross Profit---
Operating Expenses
Research Development12,37622,00518,916
Selling General and Administrative6,6676,2375,516
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-19,043-28,242-24,432
Income from Continuing Operations
Total Other Income/Expenses Net3046357
Earnings Before Interest and Taxes-18,739-28,179-24,375
Interest Expense159464475
Income Before Tax-18,898-28,643-24,850
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-18,898-28,643-24,850
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-18,898-28,643-24,850
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-18,898-28,643-24,850